Efficacy of Vayasthapana Gana and Rasayanakalpa Vati on Menopausal syndrome

A clinical study on menopausal syndrome and its management by VayasthapanaGana and Rasayanakalpa vati

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/07/006044

Enrollment

Registered

2015-07-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients who suffering from Menopausal syndrome

Interventions

Intervention1: Group A-VayasthapanaGana Ghanavati: Group A-Dose-2 tablets(500mg)BD with milk for 60 days Control Intervention1: Group B- rasayanakalpa Vati: Group B-Dose 5 tablets(500mg)BD with milk f

Eligibility

Inclusion criteria

Inclusion criteria: Amenorrhoea at least for 12 months or more. Kupperman Menopausal Index Score >= 15 FSH >= 20 IU/L Thickness of endometrium

Exclusion criteria

Exclusion criteria: Age below 40 years and age more than 55 years. Women with uncontrolled medical conditions e.g. Hypertension, Heart disease, Diabetes mellitus, Cancer. Who had the H/O Hormone replacement therapy (HRT). Women having H/O excessive and/or irregular bleeding per vaginally. Established case of mental illness.

Design outcomes

Primary

Measure	Time frame
TO EVALUATE AND COMPARE THE EFFICACY OF BOTH TRIAL DRUGS IN MENOPAUSAL SYNDROMETimepoint: 2 months in both groups	—

Secondary

Measure	Time frame
To improve the quality of life of menopausal womenTimepoint: 2 months in both groups	—

Countries

India

Contacts

Public ContactProf L P dei

Institute for Post Graduate Teaching and Research in Ayurveda

baghelayu@rediffmail.com9427207964

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026